Detection of aberrant signaling pathways in CD34+cells from patients with myelofibrosis with myeloid metaplasia using oligonulceotide microarrays.

被引：0
作者：
Jones, LC
Tefferi, A
Wachsman, W
Hofmann, WK
Koeffler, HP
机构：
[1] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Res Inst, Los Angeles, CA 90024 USA
[2] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA
[3] VASDHS, Res Serv, La Jolla, CA USA
[4] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2620
引用
收藏
页码：626A / 626A
页数：1
相关论文
共 50 条
[21]   Proteomic Profile Of CD34+Cells From Chronic Myeloid Leukemia Patients and From Normal Donors [J].
Rosaria Ricciardi, Maria ;
Salvestrini, Valentina ;
Forcato, Mania ;
Licchetta, Roberto ;
Mirabilii, Simone ;
Rossi, Lara ;
Allegretti, Matteo ;
Vincenzi, Martina ;
Salati, Simona ;
Castagnetti, Fausto ;
Rosti, Gianantonio ;
Alimena, Giuliana ;
Manfredini, Rossella ;
Bicciato, Silvio ;
Lemoli, Roberto ;
Tafuri, Agostino .
BLOOD, 2013, 122 (21)
[22]   Effect of antisense oligonucleotides on CD34+cells from chronic myeloid leukemia [J].
Pigneux, A ;
Mahon, FX ;
Jazwiec, B ;
Pigeonnier, V ;
Ripoche, J ;
Reiffers, J .
LEUKEMIA & LYMPHOMA, 2000, 36 (5-6) :569-578
[23]   Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis [J].
Briard, D ;
Brouty-Boyé, D ;
Giron-Michel, J ;
Azzarone, B ;
Jasmin, C ;
Le Bousse-Kerdilès, MC .
CLINICAL IMMUNOLOGY, 2003, 106 (03) :201-212
[24]   Circulating CD34+cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice [J].
Saito, Noriyuki ;
Yamauchi, Takuji ;
Kawano, Noriaki ;
Ono, Rintaro ;
Yoshida, Shuro ;
Miyamoto, Toshihiro ;
Kamimura, Tomohiko ;
Shultz, Leonard D. ;
Saito, Yoriko ;
Takenaka, Katsuto ;
Shimoda, Kazuya ;
Harada, Mine ;
Akashi, Koichi ;
Ishikawa, Fumihiko .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (02) :198-207
[25]   A Novel Combination of Drugs Which Target Both the Intrinsic and Extrinsic Apoptotic Pathways to Eliminate Myelofibrosis CD34+Cells [J].
Lu, Min ;
Xia, Lijuan ;
Hoffman, Ronald .
BLOOD, 2019, 134
[26]   Blood CD34 count in myelofibrosis with myeloid metaplasia: A prospective evaluation of prognostic value in 94 patients. [J].
Arora, B ;
Sirhan, S ;
Hoyer, JD ;
Mesa, RA ;
Tefferi, A .
BLOOD, 2004, 104 (11) :191A-191A
[27]   Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients [J].
Arora, B ;
Sirhan, S ;
Hoyer, JD ;
Mesa, RA ;
Tefferi, A .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (01) :42-48
[28]   CD7 expression on CD34+cells from chronic myeloid leukaemia in chronic phase [J].
Martín-Henao, GA ;
Quiroga, R ;
Sureda, A ;
García, J .
AMERICAN JOURNAL OF HEMATOLOGY, 1999, 61 (03) :178-186
[29]   Transcriptome analysis of CD34+cells from myelodysplastic syndrome patients [J].
Ou, Ruiming ;
Huang, Jing ;
Shen, Huijuan ;
Liu, Zhi ;
Zhu, Yangmin ;
Zhong, Qi ;
Zheng, Liling ;
Yao, Mengdong ;
She, Yanling ;
Zhou, Shanyao ;
Chen, Rui ;
Li, Cheng ;
Zhang, Qing ;
Liu, Shuang .
LEUKEMIA RESEARCH, 2017, 62 :40-50
[30]   INTRACELLULAR CALCIUM DEPOSITS AND STORE OPERATED CALCIUM ENTRY IN CD34+CELLS FROM PATIENTS WITH MYELOFIBROSIS CARRYING A CALR MUTATION [J].
Poletto, V. ;
Canobbio, I. ;
Pietra, D. ;
Dragoni, S. ;
Bonetti, E. ;
Campanelli, R. ;
Massa, M. ;
Fois, G. ;
Catarsi, P. ;
Villani, L. ;
Torti, M. ;
Tanzi, F. ;
Cazzola, M. ;
Moccia, F. ;
Barosi, G. ;
Rosti, V. .
HAEMATOLOGICA, 2014, 99 :120-120
12345